MeSH tree: C12.050.351.937
An ultrasound test that detected 96% of ovarian cancers in postmenopausal women should replace the current standard of care test in the UK according to a new study.
Sep 30, 2024
0
103
Hereditary changes in genes are often the cause of rare diseases. For example, disease-causing gene variants (PVs) in the HRAS gene cause Costello syndrome and PVs in the KRAS gene cause Noonan syndrome and cardio-facio-cutaneous ...
Sep 26, 2024
0
39
A new study challenges a 2019 World Health Organization report that microplastics in drinking water are harmless after confirming their presence in kidney, urine and bladder cancer samples.
Sep 26, 2024
0
64
A team of researchers at the University of Alberta has found that digoxin, a drug widely used to treat congestive heart failure, is an effective therapy for a rare and aggressive form of endometrial cancer.
Sep 16, 2024
0
24
Research from Purdue University in collaboration with the National Institutes of Health (NIH) reveals that, thanks to a new computational tool, a cancer drug dismissed by traditional testing methods may be effective in treating ...
Sep 9, 2024
0
31
A study led by researchers at UT Southwestern Medical Center reveals significant disparities across the country in the use of immunotherapy for patients with advanced kidney and bladder cancers. The findings, published in ...
Sep 4, 2024
1
34
Efforts to rule out bladder tumors and tuberculosis are still essential in the follow-up of patients with suspected interstitial cystitis (IC), according to a study published online Aug. 11 in the International Journal of ...
Sep 4, 2024
0
26
Scientists at Van Andel Institute and Icahn School of Medicine at Mount Sinai have developed a potent anti-cancer compound that inhibits cancer cell growth in a tough-to-treat type of infant leukemia. The findings are published ...
Aug 30, 2024
0
54
New insights into the biology of kidney cancer, including those informed by scientific discoveries that earned a Nobel Prize, have led to advances in treatment and increased survival rates, according to a review by UNC Lineberger ...
Aug 28, 2024
0
38
Belzutifan, a hypoxia-inducible factor 2α (HIF-2α) inhibitor, improves progression-free survival and objective responses over everolimus among patients with advanced clear-cell renal cell carcinoma, according to a study published ...
Aug 23, 2024
0
44
